Jianmin Fang, Ph.D. Chairman, and CEO

  • Ph.D. from Dalhousie University, Post-Doctorate from Harvard University
  • Distinguished expert  “China 1000 Expert Plan”
  • Distinguished expert Shandong Province “Taishan Scholar Project”
  • Expert member of National Major Science and Technology project “China National Create Significant New Drugs”(National 13/5 Plan)
  • Professor at Tongji University, Shanghai, China
  • More than 20 years of experience in monoclonal antibodies in the United States
  • Over 20 patents, including the inventor of Conbercept

James Ruan, Ph. D., SVP, Quality

  • Ph.D. from Lund University, Post-Doctorate from UCLA
  • Over 30 years experience in monoclonal antibody research and quality management
  • Member of Scandinavian Society of Immunology
  • Member of Parenteral Drug Association
  • Holds two international invention patents

Andrew C. Huang, Ph.D.,CSO

  • Ph.D. from the University of Iowa, Post-Doctorate from UCLA
  • Distinguished expert Shandong Province “Taishan Scholar Project”
  • Over 20 years research experience in Biopharmaceuticals in the United States
  • More than 25 years experience in molecular medicine

Yong Deng, VP, Admin & HR

  • BSc. from Shandong University of TCM, Senior Economist
  • Over 20 years management in pharmaceutical enterprise, keen insight in corporate development
  • Rich experience in marketing strategy, corporate operation, and capital management